Piper Sandler analyst Allison Bratzel reiterated an Overweight rating on Ionis Pharmaceuticals (NASDAQ: IONS).The analyst said: "Remain Overweight rated on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE